All Activity

Texas officials have officially adopted a set of emergency rules meant to prevent the sale of intoxicating hemp products to people under 21. After similar restrictions were implemented by the Texas Alcoholic Beverage Commission (TABC) late last month, the state Department of State Health Services (DSHS) announced on Friday that they’ve moved forward with policies changes that comply with the governor’s recent executive order on hemp. “The rules define a minor as a person under 21 years of age, require consumable hemp sellers to verify purchasers have a valid ID that shows they are at least 21 years old, and provide for penalties including the revocation of a license or registration for violations,” DSHS said. The rules are effective for 120 days, with the possibility of a 60-day extension. “At the same time, DSHS has begun the process of proposing permanent rules to implement the age requirement and other aspects of the Governor’s executive order,” the department said. “As part of that process, the public will have an opportunity to provide comments on proposed rules at a public hearing to be scheduled once those rules are published.” The reason that two agencies are issuing similar rules is that TABC only regulates retailers that sell alcohol, such as liquor stores and certain convenience and grocery stores, and thus has no jurisdiction over smoke shops and other places that sell hemp products but not alcohol. Heather Fazio, director of the advocacy group Texas Cannabis Policy Center, told Marijuana Moment on Friday that the “hodgepodge” of regulatory changes under different departments “highlights the government’s reluctance to just accept cannabis as a legal commodity.” Rather that this “duplicating of efforts and cross-talk” between agencies, it would be “so much more efficient if we had a cannabis regulatory authority in general,” she said. (Disclosure: Fazio supports Marijuana Moment’s work via monthly Patreon pledges.) This comes in the background of unsuccessful efforts to impose an outright ban on hemp products with any quantifiable amount of THC. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile this week, the head of the Texas Department of Agriculture (TDA) pushed back against a GOP senator’s “incorrect assertions” about the state’s regulatory compliance with federal hemp laws. But he also signaled that changes may be coming to measure “total THC” to determine the legality of hemp products in a way that some stakeholders worry could negatively impact the industry. After the legislature failed to pass a controversial bill to ban hemp products containing THC during two special sessions following the governor’s veto of a similar measure earlier this year, Gov. Greg Abbott (R) signed the executive order to impose certain restrictions on the market. Meanwhile, a recent survey from a GOP pollster affiliated with President Donald Trump found that Texas Democratic and Republican voters are unified in their opposition to the hemp ban proposal. Image element courtesy of AnonMoos. The post Texas Health Officials Adopt Rules To Ban Hemp THC Sales To People Under 21 In Response To Governor’s Executive Order appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

An American basketball player is potentially facing the death penalty or a lengthy prison sentence after being arrested in Indonesia over possession of marijuana gummies he said he uses for medical purposes to treat Crohn’s disease. Jarred Shaw—a 35-year-old Texan who’s played internationally for the team Prawira Bandung and helped secure a victory in the 2023 Indonesian Basketball League (IBL)—was arrested in May by Indonesian law enforcement after receiving a package of over 100 cannabis gummies. Indonesia has extremely punitive drug laws, including for marijuana, and the crime carries the possibility of capital punishment. Shaw conceded in an interview with The Guardian that was published on Friday that he made a “stupid mistake,” but he explained that he uses cannabis to treat symptoms of his gastrointestinal issues. “I use cannabis as a medicine,” he said in the interview during pre-trial detention in Jakarta. “I have an inflammatory condition called Crohn’s disease that’s incurable. There’s no medicine apart from cannabis that stops my stomach from aching.” “I made a stupid mistake,” he said. “There’s people telling me I’m about to spend the rest of my life in prison over some edibles.” “I’ve never been through anything like this,” he said, adding that during his first two months after being arrested, he was at “the lowest point in [my] life” and in a “really dark mental place.” “I felt helpless and alone. I didn’t want to wake up again,” he said. “I just turned 35 but I still feel young. I would love to continue my basketball career.” The cannabis gummies he purchased and that were delivered to him before being swarmed and arrested by police weighed 869 grams, resulting in a charge that accused him of possessing essentially a kilo of marijuana even though most of the weight was from the non-cannabis components of the edible. “They’re making it seem like I’m this big drug dealer,” Shaw said. “Why would I bring the candy here to sell? It was for personal use.” A State Department spokesperson told Marijuana Moment that “we are aware of reports of a U.S. citizen detained in Indonesia,” but that “due to privacy considerations, we have no further comment.” Marijuana Moment also reached out to the White House for comment, but representatives were not immediately available, with an automated message citing the government shutdown as the reason for unresponsiveness. So it remains to be seen whether the Trump administration will designate this as a wrongful detained individual by a foreign government, which could help secure Shaw’s release as has been the case in past marijuana-related international cases. For example, the State Department under former President Joe Biden eventually designated Marc Fogel as a wrongfully detained individual toward the end of his term, after previously resisting the move. The American teacher was serving a 14-year sentence after being convicted of “drug smuggling” over possession of a half-ounce of cannabis. Fogel was a registered medical marijuana patient in Pennsylvania prior to the imprisonment, and after his release under the Trump administration, he’s now scheduled to advocate for cannabis reform at an event in the state on Saturday. Ahead of his designation as wrongfully detained, there were repeated calls for the diplomatic status change, including a letter sent to the Biden administration by over a dozen members of Congress that emphasized that Fogel’s access to marijuana was “necessary to subdue his pain.” Brittney Griner—a U.S. professional basketball player who was previously incarcerated in Russia over possession of marijuana—was also set to attend a cannabis advocacy event earlier this year. But she ultimately pulled out after discovering what she felt was a threatening message in her hotel room. The lack of clarity on next steps in Shaw’s case, meanwhile, is heightened by the recent upsurge in anti-drug activity from the Trump administration, which has included declaring a “non-international armed conflict” with cartels that officials have used to justify attacks on ships suspected of trafficking illicit drugs. But as President Donald Trump continues to weigh a pending marijuana rescheduling proposal he said would be decided on imminently, he also shared a video last week that touted the health benefits of hemp-derived CBD. Photo courtesy of Chris Wallis // Side Pocket Images. The post American Basketball Player Faces Potential Death Penalty Over Medical Marijuana After Arrest In Indonesia appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

New Hampshire lawmakers have advanced a bill to allow medical marijuana dispensaries in the state to convert from from non-profit organizations to for-profit businesses. After clearing an initial committee and then passing the full House of Representatives in March, the legislation from Rep. Wendy Thomas (D) returned to the House Finance Committee under rules for measures with fiscal implications. A subcommittee of that panel unanimously approved the proposal in a 9-0 vote on Thursday. Rep. Carol McGuire (R) noted the near unanimity of support in the chamber as the legislation has moved through the process—with a fiscal note that showed a $13,000 cost estimate to implement the law that narrowly rose to the occasion of triggering a Finance Committee review. “This is something that will let the alternative treatment centers operate more efficiently and, with any luck, will lower the cost to our medical cannabis users. So I’m in strong support,” she said. Part of the motivation behind the legislation is the fact that medical marijuana dispensaries, called alternative treatment centers (ATCs) under New Hampshire law, don’t qualify for federal non-profit status. But in the state, they’re considered non-profit organizations, which has resulted in disproportionately increased operating costs. Advocates say those costs are then passed on to patients, necessitating the policy change. And they also argue that the current policy is pushing adults outside of the New Hampshire program, with many purchasing products in surrounding states with legal cannabis programs. “It’s encouraging to see that this issue continues to enjoy strong, bipartisan support in the House,” Matt Simon, director of public and government relations at the medical marijuana provider GraniteLeaf Cannabis, told Marijuana Moment. “The current business structure requirement for ATCs makes no sense and does not benefit patients in any way.” (Disclosure: Simon supports Marijuana Moment’s work with a monthly pledge on Patreon.) Similar legislation has advanced through both chambers in recent sessions but was vetoed by the governor. In 2019, a proposal passed the House and Senate, but a veto override attempt failed by just one vote in the Senate. In 2022, the override attempt failed by a single vote in the House. Sen. Daniel Innis (R) has signaled his intent to file a bill in the Senate on the issue for the 2026 session. Meanwhile, a New Hampshire House committee recently discussed plans to move forward with a bill to legalize marijuana altogether–even though members accept that it is unlikely to advance beyond the chamber given opposition in the Senate and the threat of a veto by the governor. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — “We know where it’s going to go. Let’s send a virtue signal,” the sponsor of the legalization proposal, Rep. Jared Sullivan (D), said during a House Commerce and Consumer Affairs Committee hearing last month. “Let them be the ones that are pissing off voters who care about this.” Sullivan ultimately made a persuasive defense of moving forward with his original bill, pointing out that the House has repeatedly passed similar legalization legislation and that the chamber should stand its ground, forcing the Senate and governor to again go on record with their opposition to a policy popular among voters. Meanwhile, after the House added provisions to a Senate-passed bill that would allow medical marijuana patients to grow cannabis at home, those measures were stripped in conference. Gov. Kelly Ayotte (R) also said in August that her position on marijuana legalization would not change even if the federal government moved forward with rescheduling the plant—a policy change President Donald Trump is actively considering. “If federal law changes, I have to comply with federal law,” Ayotte said. “But my position has been, and continues to be, that we should not legalize marijuana in the future.” The post New Hampshire Lawmakers Approve Bill To Let Medical Marijuana Dispensaries Convert To For-Profit Businesses appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A new cannabis compound that appears to have “remarkable antioxidant and skin anti-inflammatory” properties has been discovered by scientists. The isolated cannabinoid, classified as cannabizetol (CBGD), shows promise for the expanding base of knowledge regarding the therapeutic and medicinal potential of the marijuana plant. Cannabizetol is formed when two cannabinoid molecules bind together with a methylene bridge, the researchers explained in a new paper. Aside from its promising medical findings, cannabizetol is also one of the rare compounds in a class known as dimeric cannabinoids, one of only four dimeric molecules currently identified in cannabis. “We demonstrate that cannabizetol exhibits remarkable antioxidant and skin anti-inflammatory activity, significantly higher than that observed for the known dimeric cannabinoid cannabitwinol,” the study says. “These results highlight cannabizetol as a promising bioactive metabolite with potential dermatological applications.” The Italian and Swiss authors, writing in the September 2025 issue of the peer-reviewed Journal of Natural Products, said their results “suggest that among the many still unknown cannabinoids there are also methylene-bridged dimers of other cannabinoids, including dimers composed of two different cannabinoids, with potential biological activities of great interest.” “The synthesis of analytical standards could be useful in facilitating the identification of these compounds in cannabis extracts,” they wrote—adding that “natural dimeric compounds are of considerable importance, as they enable further exploration of chemical space, potentially leading to novel biological activities beyond those of their respective monomers.” The researchers used a number of inflammatory genes to test against CBGD. After a six-hour treatment, “the anti-inflammatory activity of the molecules was evaluated on 84 inflammatory genes using an RT-PCR array (RT2 Profiler PCR Array Human Inflammatory Cytokines and Receptors, QIAGEN S.r.l., Hilden, Germany), as previously described” they wrote. The chemists examined NF-κB, a molecular pathway that seems to serve as a master switch for inflammation, given the prolific nature of its impact across a wide range of cells that lead to the condition. Cannabinzetol appeared to show significant potential to inhibiting inflammation. “Several cannabinoids have demonstrated biological activities, making Cannabis sativa particularly attractive as a source of potential medicinal active principles,” they noted. This study comes as the sophistication of testing equipment in the past decades has significantly increased, allowing scientists to study an ever growing array of cannabinoids. The number of known cannabinoids is over 100, though many require further study to characterize them. “The significant biological activity of these dimeric cannabinoids prompted us to optimize the synthetic approach by exploiting the flow chemistry technology,” the authors wrote. Growing on past research, this study is groundbreaking. The primary intoxicating compound in the marijuana plant, well known to the public, is THC, isolated and discovered by an Israeli scientist in 1964. It wasn’t until the 1990s that the endocannabinoid system was identified in rats and humans. Building on that knowledge, chemists isolated other compounds with potential therapeutic effect, including cannabigerol and cannabinol. This comes as a cascading flow of new research on cannabinoids are classified. Scientists reported in May 2025 that they identified 33 “significant markers” in the cannabis genome that “significantly influence cannabinoid production”—a finding they say promises to drive the development of new plant varieties with specific cannabinoid profiles. Additionally, researchers announced in April 2025 that they successfully identified a new cannabinoid—cannabielsoxa—produced by the marijuana plant as well as a number of other compounds “reported for the first time from the flowers of C. sativa.” The team of government and university researchers out of South Korea also evaluated 11 compounds in cannabis for antitumor effects in neuroblastoma cells, finding that seven “revealed strong inhibitory activity.” The post Scientists Discover New Cannabis Compound With ‘Remarkable Antioxidant And Skin Anti-Inflammatory’ Benefits appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Kentucky medical marijuana cultivation facility has harvested its first yield of cannabis, and patients could gain access to it by next month, a top regulator says. Meanwhile, the governor says licensed businesses are about to “grow a whole lot more” as the program gets underway. Cannon Armstrong, executive director of the Office of Medical Cannabis (OMC), said one of the state’s cultivators “produced their first harvest, and it’s up to the cultivator and the licensee on where they move and when they move on that.” “I suspect that if we’re going to try and say timeframes—that it’ll definitely be before the end of the year, we’re hopeful that it may be November,” he told WAVE 3. That pushes back the timeline slightly after Armstrong previously estimated a few weeks ago that sales could begin this month—but Gov. Andy Beshear (D) said this is just the start of a robust medical cannabis market in the commonwealth. “Since taking office, my administration has been committed to providing access to health care and safe communities for all Kentuckians,” the governor said. “One of our priorities is ensuring that Kentuckians that are suffering from serious medical issues like cancer, PTSD or multiple sclerosis can have safe access to medical cannabis as soon as possible to get the relief they need.” He also announced that, although licensed operators are actively growing cannabis plants to bring to market, “we’re about to grow a whole lot more,” adding that as of Thursday, OMC approved “another cultivator to begin cultivation activities here in Kentucky, and this one is a big one.” Beshear was talking about Natural State GreenGrass CannaCo, a tier III cultivation facility, which is “one of the two largest cultivation facilities in Kentucky.” “They’ll eventually expand all 25,000 square feet of cultivation space,” he said. “This operator and so many more will help us ensure for years to come that Kentuckians suffering from serious medical conditions can get the relief they deserve.” Last month, Beshear said he thought medical marijuana would be available to Kentucky patients by the end of 2025. “The medical marijuana program is moving forward,” he said at a press briefing at the time. “I think most of our dispensaries now have their home address [and] are set about where they’re going to be, but [for] some of the inspections that have to happen in dispensaries, they have to have product that’s there,” he said. “So I do believe they’ll be operating before the end of the year.” Those comments came roughly a month after the governor announced that the state’s first medical cannabis dispensary has officially been approved for operations, calling it “another step forward as we work to ensure Kentuckians with serious medical conditions have access to the medicine they need and deserve. He previously touted an earlier “milestone” in the state’s forthcoming medical marijuana program, with a licensed cultivator producing “the first medical cannabis inventory in Kentucky history.” Beshear’s office has said that other cannabis licensees, including processors and testing labs, are expected to become operational soon. In July, Beshear sent a letter to President Donald Trump, urging him to reject congressional spending bill provisions that would prevent the Justice Department from rescheduling marijuana. In the letter to the president, he emphasized that a pending proposal to move cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA) is something “you supported in your presidential campaign.” “That process should be allowed to play out. Americans deserve leadership that won’t move the goalposts on them in the middle of the game,” Beshear said, noting that he was among the tens of thousands who submitted public comments in favor of the reform after it was initiated under the Biden administration, “demonstrating broad public interest in rescheduling.” “I joined that effort because this is about helping people. Rescheduling would provide suffering patients the relief they need,” the governor said. “It would ensure communities are safer—because legal medical products reduce the illicit market. It would provide new, meaningful research on health benefits.” Beshear also mentioned a letter to DEA he signed onto last year urging rescheduling, “because the jury is no longer out on marijuana. It has medical benefits.” Back on the state level, the governor recently said he acknowledges that “it’s taken longer than we would have liked” to stand up the industry since he signed medical marijuana legalization into law in 2023. In recognition of that delayed implementation, he recently signed an executive order to waive renewal fees for patients who get their cards this year so that they don’t get charged again before retailers open. And another order he signed providing protections for qualified patients who obtain medical marijuana outside of Kentucky “will stay in place.” Beshear separately announced in May that the state has launched a new online directory that lets people see where medical cannabis dispensaries will be opening near them. He emphasized that the state has been working to deliver access to patients “at the earliest possible date,” and that involved expediting the licensing process. The governor in January also ceremonially awarded the commonwealth’s first medical marijuana cards. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, the governor sent a letter to Kentucky’s congressional delegation in January, “urging them to take decisive action to protect the constitutional rights of our law abiding medical cannabis patients” by repealing the federal ban on gun possession by people who use marijuana. That came after bipartisan Kentucky senators filed legislation that similarly called on the state’s federal representatives to take corrective action, which Beshear said he supports but would like to see even more sweeping change on the federal level. The federal Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) warned Kentucky residents late last year that, if they choose to participate in the state’s medical marijuana program, they will be prohibited from buying or possessing firearms under federal law. As far as the implementation of the state’s medical cannabis law goes, Beshear said in his State of the Commonwealth address in January that patients will have access to cannabis sometime “this year.” He also later shared tips for patients to find a doctor and get registered to participate in the cannabis program. Health practitioners have been able to start assessing patients for recommendations since the beginning of December. While there currently aren’t any up-and-running dispensaries available to patients, Beshear has further affirmed that an executive order he signed in 2023 will stay in effect in the interim, protecting patients who possess medical cannabis purchased at out-of-state licensed retailers. During last year’s November election, Kentucky also saw more than 100 cities and counties approve local ordinances to allow medical cannabis businesses in their jurisdictions. The governor said the election results demonstrate that “the jury is no longer out” on the issue that is clearly supported by voters across partisan and geographical lines. Photo courtesy of California State Fair. The post Kentucky Cultivator Harvests State’s First Medical Marijuana Crop As Governor Predicts Farmers Will ‘Grow A Whole Lot More’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“There was a willingness to consider multiple ways to get enough revenue… This just happened to be the one that could get the votes.” By Ben Solis, Michigan Advance After much hand wringing and consternation from lawmakers who feared detrimental effects to Michigan’s cannabis industry, the Michigan Senate voted early Friday morning by a thin margin to pass a 24 percent wholesale tax on marijuana products sold in the state. The measure is estimated to raise $420 million in new revenue to fund road repairs and construction in the new fiscal year, a key component of the budget deal reached by Gov. Gretchen Whitmer (D), House Speaker Matt Hall (R-Richland Township) and Senate Majority Leader Winnie Brinks (D-Grand Rapids). If the vote had failed, the entire deal would more than likely fall apart, sending the respective chambers and the governor’s office back to the negotiating table. Such a development would have also sent the state into a full government shutdown. House leadership said Thursday that it would not entertain another continuation budget after the one passed Wednesday expired after October 8. Although many members of the cannabis industry rallied at the Capitol and lobbied lawmakers against passing the legislation, the implications of the entire deal falling through weighed heavily on the Legislature’s mind. The House and Senate on late Thursday and early Friday morning passed their respective conference budgets to fund the whole of government, K-12 schools and higher education, but all of that hinged on passage of the marijuana tax. The bill passed by a slim 19-17 vote, which had nearly as much bipartisan dissent as it did support. Brinks and the following senators voted in favor of the bill: Sarah Anthony (D-Lansing), Rosemary Bayer (D-West Bloomfield), Darrin Camilleri (D-Trenton), Mary Cavanagh (D-Redford Township), Stephanie Chang (D-Detroit), John Cherry (D-Flint), Kevin Daley (R-Lum), Erika Geiss (D-Taylor), Veronica Klinefelt (D-Eastpointe), Dan Lauwers (R-Brockway), Ed McBroom (R-Vulcan), Sean McCann (D-Kalamazoo), Mallory McMorrow (D-Royal Oak), Jeremy Moss (D-Bloomfield Township), Dayna Polehanki (D-Livonia), Sam Singh (D-East Lansing), Roger Victory (R-Georgetown Township) and Paul Wojno (D-Warren). Sen. Jeff Irwin (D-Ann Arbor) voted no against the bill. He was one of the legislation’s strongest opponents. Irwin was joined by Sens. Thomas Albert (R-Lowell), Joseph Bellino (R-Monroe), Jon Bumstead (R-North Muskegon), John Damoose (R-Harbor Springs), Roger Hauck (R-Mount Pleasant), Kevin Hertel (D-Saint Clair Shores), Michele Hoitenga (R-Manton), Mark Huizenga (R-Walker), Ruth Johnson (R-Groveland Township), Jonathan Lindsey (R-Coldwater), Senate Minority Leader Aric Nesbitt (R-Porter Township), Jim Runestad (R-White Lake), Sylvia Santana (D-Detroit), Sue Shink (D-Northfield Township), Lana Theis (R-Brighton) and Michael Webber (R-Rochester Hills). A large portion of the day was spent debating the measure in caucus meetings and whipping votes to ensure the tax did not go up in smoke. Brinks and Hall were repeatedly seen in the Capitol meeting on the chamber floors and entering offices to discuss the status behind closed doors. Whitmer also called groups of lawmakers into her Capitol office at multiple points throughout the afternoon and evening on Thursday. One of those lawmakers was Chang, who on Tuesday put forward an amendment to the marijuana tax that would have brought the rate down to 20 percent, with the caveat of a tie-bar to the senator’s proposed nicotine products and e-cigarettes tax. Chang surmised that the amendment would not be taken up in an interview with Michigan Advance. When she left Whitmer’s office on Thursday evening, she was asked if she and the governor had discussed her proposal. Chang said that they had. As to whether the proposal was likely a new vehicle for what appeared to be a flailing 24 percent rate, Chang would not comment on how the Senate planned to vote. She also said then that she was undecided on the 24 percent tax. The conversation in the House veered wildly as the day and night wore on. At first, Hall was confident that the measure, which originated in the House, would pass because Brinks proposed it when they began negotiations for new revenue. The House speaker also cautioned that not following through on passage would scuttle their loose deal with Whitmer on revenue for roads. That would have also meant a new phase in the budget crisis—a real government shutdown, given Hall’s unwillingness to pass another continuation budget. With several senators expressing opposition to the tax, it became possible that the deal could careen off a cliff of Brinks’s own making, and key members of the House started shifting their tone from hopeful anticipation to stark warnings about the deal falling apart. In the end, the Senate whipped up just enough bipartisan votes to get the tax across the finish line. For Irwin’s part, he issued a floor speech echoing some of his comments made earlier when the tax was proposed. Lindsey also said he would vote no in a floor speech. He indicated that it bothered him that some members of the upper chamber were gleefully willing to vote yes, specifically due to the potential impacts: a shrinking of the industry because of a higher tax burden and potential closures of dispensaries across Michigan. McBroom was one of those yes votes on the GOP side. In his own floor speech, he said that the industry failed to meet its promise to fill state coffers with new tax revenue to a significant degree, and that maybe a right-sizing of the industry was in order. McBroom said he wished the tax rate was even higher than what was proposed. To some of the industry leaders who vehemently opposed the tax, McBroom said the law that legalized marijuana and set up a regulatory and tax scheme always referenced avenues for collecting other taxes related to marijuana sales. Brinks had a fight on her hands to get the necessary votes, but she was victorious at 4 a.m. on Wednesday morning when she spoke to members of the Capitol press corps. “It was tough to fit it in with the rest of the demands of the budget and still be responsible, but we managed to do it,” Brinks said. “I think there was a willingness to consider multiple ways to get enough revenue… This just happened to be the one that could get the votes. I do know that politics is really the art of what’s possible, and in this case, that’s the road it led us down, no pun intended.” This story was first published by Michigan Advance. The post Michigan Lawmakers Approve Marijuana Tax Increase Projected To Raise $420 Million In Annual Revenue appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Our Gurgaon Call Girls are classic companions who know how to give chills with their devastating beauty and jovial nature. These dazzling escorts turn every dull night into unceasing fun. Whether you choose an in-call hotel service or private outcall, they guarantee mesmerizing erotic services with full cooperation to your desires.

FL marijuana smell court ruling; OR interstate cannabis commerce lawsuit; NY psychedelics hearing; Survey: Medical marijuana helps chronic pain Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW California Gov. Gavin Newsom (D) joked in another Trump-style social media post that he will be legalizing marijuana nationwide under the new role of “leader of the free world” he’s proclaiming in light of the federal government shutdown—saying that people will be “high on patriotism.” California Gov. Gavin Newsom (D) signed a bill to integrate intoxicating hemp products into the state’s existing marijuana market—saying that “for too long, nefarious hemp manufacturers have been exploiting loopholes to make their intoxicating products easily available to our most vulnerable communities.” The Florida Second District Court of Appeal ruled that police cannot search a person’s vehicle based only on the smell of cannabis—determining that the legalization of medical marijuana and hemp have “fundamentally changed” the plant’s “definition and regulation.” An Oregon marijuana business filed a federal lawsuit seeking to overturn the state’s ban on cannabis exports and imports to and from other states—arguing that prohibiting interstate commerce violates the U.S. Constitution’s Dormant Commerce Clause. The New York Assembly Health Committee held a hearing on psilocybin—taking testimony about the therapeutic potential of the psychedelic from medical professionals, researchers, patients and advocates. A new survey shows that 86 percent of patients say medical cannabis improved their chronic pain moderately or significantly—and that using marijuana helped to completely eliminate the use of prescription drugs for one in three patients. Michigan House Speaker Matt Hall (R) is threatening to walk away from budget negotiations and effectively shut down the state government if the Senate doesn’t agree to a marijuana tax increase. The Kansas Bureau of Investigation launched raids against retailers engaging in “brazen” sales of cannabis and THC products in six cities across the state. / FEDERAL The White House sent Congress a notification that President Donald Trump has determined that drug cartels are “nonstate armed groups” whose actions “constitute an armed attack against the United States,” and the country is thus engaged in a formal “armed conflict” with them. The Drug Enforcement Administration is placing the cannabinoid type 1 receptor agonist MDMB-4en-PINACA in Schedule I, saying its pharmacological action is “similar to other schedule I cannabinoids, such as Δ9-tetrahydrocannabinol (Δ9-THC), which all have high abuse potential.” / STATES A Kansas Court of Appeals panel will hear a case about whether the smell of cannabis provides reasonable suspicion for police searches on October 14. A Minnesota regulatory spokesperson addressed concerns about medical cannabis businesses’ heads start on recreational marijuana sales. New Jersey regulators acted on marijuana business licensing and violation issues. Oregon regulators are accepting applications to serve on a psilocybin services rules advisory committee. The New Hampshire Therapeutic Cannabis Medical Oversight Board will meet on Wednesday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The Killeen, Texas City Council is considering authorizing more funding to defend the city’s voter-approved marijuana decriminalization law from lawsuit filed by Bell County. The La Crosse County, Wisconsin Board chair discussed a proposal to reduce the fine for marijuana possession to $1. / INTERNATIONAL Moroccan officials signed medical cannabis agreements with specialized medical associations. / SCIENCE & HEALTH A study found that “low-frequency cannabis use among older adults, including those along the dementia continuum, is generally well tolerated from a cognitive perspective.” A review concluded that “cannabinoids produced a modest but statistically significant reduction in pruritus, suggesting clinical relevance for symptom management.” / ADVOCACY, OPINION & ANALYSIS A Citizens for a Safe and Healthy Texas official authored an op-ed arguing that “if Republicans want to honor Charlie Kirk, they will stand up for a generation of young Americans being preyed on by the marijuana industry.” / BUSINESS Curaleaf Holdings, Inc.’s executive vice chairman established an automatic securities disposition plan. Herbarium owners are being sued for allegedly wrongfully terminating an employee who complained about unpaid overtime, stolen tips and other issues. Vertanical announced positive results from Phase 3 clinical studies of its standardized full-spectrum cannabis extract. Innovative Industrial Properties, Inc. closed its initial investment into IQHQ, Inc. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Newsom talks national cannabis legalization in Trump-mocking post (Newsletter: October 3, 2025) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Hiring a beautiful Escort In Gurgaon is the easiest way to bring your fantasies to life. These mesmerizing call girls provide both in-call and outcall services, ensuring maximum entertainment without any disturbance. With their classic skills and appealing personalities, they can make every moment of your adult dream a delightful, unforgettable encounter.

This is a fantastic initiative! Ensuring equality involves transparent policies and unbiased promotion opportunities. I'd love to share my experience, covering soil prep, watering, and feeding. It feels like solving a daily Wordle Unlimited puzzle, figuring out the best combination for optimal growth! Record keeping is also crucial for future success. Let's cultivate a thriving garden and empower each other!

“If our prices are no longer attractive to customers in Michigan or from other states, we’re going to lose a lot of those customers.” By Ben Solis, Michigan Advance The leader of the Michigan House of Representatives said Thursday that he expects his Senate counterpart will deliver the votes needed to pass a proposed 24 percent wholesale tax on marijuana, and if not, he says the budget deal would fall apart at the seams. Such a scenario would also lead to a full Michigan government shut down, as House Speaker Matt Hall (R) reiterated that there will not be another continuation budget to keep the lights on if the deal brokered between him, Senate Majority Leader Winnie Brinks (D) and Gov. Gretchen Whitmer (D) falls apart. “This was a revenue source that Winnie Brinks offered in private,” Hall said while speaking to reporters on Thursday. “We took them up on their suggestion of marijuana, and we all made a deal on the budget. Brinks would never make that deal if she can’t perform.” It was now on the Senate to keep up their end of the road funding deal, Hall added. A message seeking comment on the state of the marijuana tax from Brinks’s office was not returned at the time of publication The tax has opposition from some members of the House and Senate, although Hall has said throughout the week that the plan was put forward by Brinks. The tax outlined in House Bill 4951 was initiated in the lower chamber, however, sponsored by Rep. Samantha Steckloff (D-Farmington Hills). That remains to be seen, given that at least one Democrat–Sen. Jeff Irwin of Ann Arbor–said that he would not vote for the measure as is. Michigan cannabis industry stakeholders spent Tuesday in Lansing, lobbying lawmakers and rallying in hopes that the Legislature would either walk away from its proposed tax to fund roads or amend the bill to rescue the tax but at a much more palatable rate. On Tuesday, lawmakers worked late into the evening to move implementation bills that would set up passage of a final budget in the coming days. It was during that late-night session that an amendment to the proposed tax emerged in the Senate’s session database that would reduce the proposed tax to just 20 percent. The amendment to House Bill 4951, put forward by state Sen. Stephanie Chang (D-Detroit) would also tie-bar the bill to Chang’s proposed tax on several tobacco products and levying a tax on e-cigarettes–Senate Bill 582. If it were to gain traction, it could give some comfort to cannabis industry leaders who said the tax in its current proposed form would lead to a shrinking of the industry and job losses, but some opponents to the tax say that the number is still too high and wouldn’t get their votes. Senate Bill 582 is in line with a bill she offered during the previous legislative session which levied an additional 75 mills on top of the tax levied on cigarettes, increasing the wholesale tax on cigars, noncigarette smoking tobacco, smokeless tobacco, and any tobacco product to 57 percent while levying a 57 percent wholesale tax on e-cigarettes. In an interview with Michigan Advance, Chang said the amendment amounted to a concept of a plan, so to speak, and that she was just throwing it out there to see what the appetite was. She was not confident that it would be taken up, or pass even if it did. Two House lawmakers said during an anti-marijuana tax rally held Tuesday that they were working behind the scenes to get that rate reduced. Chang was asked if she’s talked to her colleagues about the amendment, particularly on the House side, but she said she had not. Irwin, who has been a strong critic of the House Republican’s proposed marijuana tax, said the reduction in the rate was an improvement, but not enough to bring him on board. “I think it would still drive a lot of people out of the legal market, still discourage a lot of people from other states who are currently coming here because our prices are advantaged,” Irwin said. “And so if our prices are no longer attractive to customers in Michigan or from other states, we’re going to lose a lot of those customers.” Now is not the time to be levying additional taxes on cannabis, Irwin argued, noting that a black market for the product still exists, and driving people toward that market will lead to a decrease in revenue. That was the sentiment shared by industry advocates at the rally on Tuesday. Irwin also argued that lawmakers should respect the distribution model for cannabis taxes that voters approved when they voted to legalize the drug in 2018. “If we’re going to change that, we certainly should have a three quarters majority to change it as demanded by the Michigan Constitution,” Irwin said. Still, Hall thought that the deal on 24 percent would hold. He was adamant that he thought the initially proposed 32 percent tax on marijuana was too high, and that the House was able to bring that number down. Hall also wondered if the tax would change consumption habits, ultimately affecting the revenue the state could get from it. Chang would not discuss her reasoning behind the amendment other than that it was another option. When asked if the House would concur with the amendment if it somehow passed, Hall was noncommittal and said again that they had a deal. “If they try to change the terms of that deal, we would strip it out and we’d send it back the other way, because there are hundreds of things we could renegotiate in this deal, but then the government would shut down,” Hall said. Michigan Advance reporter Kyle Davidson contributed to this story. This story was first published by Michigan Advance. The post Michigan House Speaker Threatens To Shut Down Government If Marijuana Taxes Aren’t Increased appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The governor of California has signed a bill to integrate intoxicating hemp products into the state’s existing marijuana market—an attempt to consolidate the cannabis industry and prevent youth access to unregulated hemp. After the legislation from Assembly Majority Leader Cecilia Aguiar-Curry (D) passed the Senate last month, Gov. Gavin Newsom (D) signed it into law on Thursday. “We are continuing to place the safety of every Californian first,” Newsom said. “For too long, nefarious hemp manufacturers have been exploiting loopholes to make their intoxicating products easily available to our most vulnerable communities—that stops today.” This follows the governor’s emergency order last year that outright prohibited hemp products with any trace amounts of THC from being sold, which industry stakeholders warned would devastate the marketplace. Under the newly signed bill, intoxicating hemp products that meet certain regulatory requirements would be able to be sold at licensed cannabis retailers with age restrictions and testing rules. But it’s unclear how that might ameliorate the hemp industry’s concerns, when adults and patients go to a store with the option to buy a broader array of marijuana products. “Bad actors have abused state and federal law to sell intoxicating hemp products in our State. As the author of legislation that allowed the legal sale of non-intoxicating hemp CBD products, this is absolutely unacceptable,” Aguiar-Curry said. “AB 8 is a result of years of collaboration with this Administration, and I appreciate the Governor’s signature.” “Our first job is to protect our kids and our communities,” she said. “With this bill, we’ll have responsible regulation, increase enforcement, and support struggling legal cannabis businesses against criminal competition.” Nicole Elliott, director of the Department of Cannabis Control (DCC), said the legislation represents “a critical step forward for California’s cannabis industry and for consumer safety.” “By closing loopholes around intoxicating hemp products and bringing them under the same strict rules as cannabis, this legislation protects consumers, ensures fair competition for licensed businesses, and strengthens the integrity of our regulated marketplace,” she said. “AB 8 makes it clear that all intoxicating products must be held to the same important standards Californians expect.” The key provisions of the law take effect in January 2028, mandating that consumable hemp products with cannabinoids other that CBD must comply with the state’s current medical and recreational marijuana laws. A Senate analysis of the bill released last month said the measure would ban the sale of “synthetic cannabis products and inhalable cannabis products containing cannabinoids derived from hemp,” place restrictions on incorporating raw hemp extracts into foods and beverages and expand “the authority for state and local enforcement agencies to inspect, seize, and destroy unlawful cannabis products.” This all follows Newsom announcing emergency regulations last year to outlaw hemp products with any “detectable amount of total THC.” Under that move, hemp products that don’t have THC are also limited to five servings per package, and sales are restricted to adults 21 and older. The proposal came less than a month after the state legislature effectively killed a governor-backed bill that would have imposed somewhat similar restrictions on intoxicating hemp-derived cannabinoids. All told, the newly enacted legislation represents a major paradigm shift in California hemp policy at a time when multiple states, as well as Congress, are considered similar restrictive changes to cannabis laws since hemp was federally legalized under the 2018 Farm Bill. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In Texas, for example, an effort to ban hemp products with THC failed in the legislature for a second time over the summer during a special session—after the Republican governor vetoed an initial version of the proposal. However, Gov. Greg Abbott (R) did subsequently sign an emergency order to impose age and labeling restrictions on consumable hemp. The head of the Texas Department of Agriculture (TDA) has since pushed back against a GOP senator’s “incorrect assertions” about the state’s regulatory compliance with federal hemp laws. But he’s also signaling that changes may be coming to measure “total THC” to determine the legality of hemp products in a way that some stakeholders worry could negatively impact the industry. At the congressional level, bipartisan House lawmakers recently criticized attempts to ban hemp THC products, arguing that it would “deal a fatal blow” to the industry and, as currently included in a spending bill, violates congressional rules. To that end, the members say there are plans in the works to introduce an alternative measure to regulate the market. Dozens of hemp farmers from Kentucky also recently urged their state’s senior U.S. senator, Sen. Mitch McConnell (R-KY), to back off from his push to recriminalize some products that are derived from their crops. Sen. Rand Paul (R-KY), for his part, recently cautioned that the cannabis policy movement has “swung hard on the prohibitionist side” amid the ongoing debate over intoxicating hemp products. And he worries that, if things go awry, the hemp market could be decimated “within the next two weeks.” Asked about recent conversations with McConnell and Rep. Andy Harris (R-MD), Paul said “we’ve been working diligently” with the staff “trying to reach a compromise.” Meanwhile, back in California, the governor has signed legislation to delay a marijuana tax hike for three years. Newsom, in keeping with his recent parody of President Donald Trump’s social media style, separately joked on Wednesday that he’s assuming the role of “leader of the free world” in light of the federal government shutdown—and part of his platform will be to legalize marijuana. Image element courtesy of Gage Skidmore. The post California Governor Signs Bill To Integrate Hemp And Marijuana Markets After Banning Intoxicating Cannabinoids Outside Of Dispensaries appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

An Oregon marijuana business has filed a new federal lawsuit against the state, challenging the constitutionality of laws prohibiting interstate cannabis commerce. After filing an initial suit in 2022—and later withdrawing it amid expectations of unspecified “big things” coming—the cannabis wholesaler Jefferson Packing House (JPH) filed a revised complaint on Wednesday with the U.S. District Court for the District of Oregon. The latest suit is lengthier than the original, and it makes additional arguments about the alleged illegality of state laws barring marijuana and hemp businesses from exporting products across state lines. At issue in the case is the Dormant Commerce Clause (DCC) of the U.S. Constitution, which generally prevents states from imposing restrictions on interstate commerce in order to ensure competitiveness in the open market. While marijuana remains federally illegal, the plaintiffs assert that the DCC still precludes Oregon from imposing trade restrictions between states. “Oregon law harms JPH by increasing its operating costs and preventing it from taking advantage of economies of scale,” the filing states, adding that state statute also harms the business with respect to hemp, which was federally legalized under the 2018 Farm Bill. Barring exports of marijuana and hemp puts JPH “at a competitive disadvantage in the market,” the complaint says, because it can’t source cannabis products from out of state and can’t ship products outside of Oregon, “both of which limit its customer base and ability to offer a complete range of products at the best prices.” State law “discriminates against interstate commerce by nakedly prohibiting such commerce, without any legitimate, non-protectionist purpose, and is therefore prohibited by the Dormant Commerce Clause of the U.S. Constitution,” it says. “There is no constitutionally adequate reason for Oregon, or any other State, to bar the import or export” marijuana or hemp. “Attempting to appease the perceived enforcement priorities of the federal government to induce the DOJ to continue its policy of non-enforcement of state-legal marijuana activities (which violate federal law equally as much as interstate commerce in marijuana) implicates fatal separation of powers concerns, as only Congress can authorize the States to regulate interstate commerce, not the DOJ, an agency of the executive branch.” Therefore, JPH is requesting that the court declare state law prohibiting interstate commerce unconstitutional, enjoin the state from enforcing the law and pay legal fees associated with the lawsuit. In a blog post about the case, attorney Vince Sliwoski of the firm Harris Sliwoski said that, if the plaintiffs were to prevail in the suit, “Oregon would have the right to appeal, of course, and likely would; and it’s possible the Ninth Circuit would take up the case. The final stop would be the U.S. Supreme Court, though a very small percentage of federal cases get that far.” But this is the second time JPH has attempted to overturn the state law and gain the right to engage in interstate commerce, which was technically legalized in Oregon under a bill signed by then-Gov. Kate Brown (D) in 2019. That law stipulates, however, that allowing for imports and exports of cannabis across state lines is contingent on a change in federal policy. Lawyers for the state previously asked the court to dismiss the earlier case, asserting that JPH lacked standing. In a motion, they wrote that because federal law also prohibits the export of cannabis products, the company’s “alleged injuries are not likely to be addressed by the relief that it is seeking.” Further, they argued the DCC does not apply as the lawsuit describes it. “That doctrine prohibits states from treating interstate and intrastate commerce differently,” the state’s filing said. “Here, however, there is no interstate commerce to treat differently.” A reply last March from Jefferson, however, contended that the federal Controlled Substances Act (CSA) “did not ‘eliminate’ commerce in marijuana any more than a criminal statute ‘eliminates’ the act or conduct it forbids.” It remains unclear what might have led the company to drop its prior legal challenge. Federal rescheduling of marijuana—as is currently being contemplated by the Trump administration—would conceivably allow some cross-border cannabis trade, at least of any medications approved by the Food and Drug Administration (FDA), but it’s unlikely a Schedule III designation in itself would allow state-licensed cannabis businesses to broadly engage in interstate commerce. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Oregon, California and Washington State have each enacted laws related to interstate cannabis commerce in recent years. In 2022, a federal appellate court ruled that Maine’s law prohibiting non-residents from owning medical marijuana businesses in the state violated the DCC. Some experts believe the same rationale invalidating the residency restrictions comes into play with state-level bans on marijuana imports and exports. Disallowing imports and exports of medical cannabis between consenting states could be construed as similarly protectionist and unconstitutional, the thinking goes. Separately in Oregon, the governor and other state officials are asking a federal appeals court to reverse a judge’s decision blocking a voter-approved law to require licensed marijuana businesses to enter into labor peace agreements with workers and mandate that employers remain neutral in discussions around unionization. Read the Oregon cannabis interstate commerce legal complaint below: Photo courtesy of Mike Latimer. The post Oregon Marijuana Business Files New Lawsuit Challenging Ban On Interstate Cannabis And Hemp Commerce appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Medical marijuana patients with chronic pain overwhelmingly agree the cannabis is an effective, long-term treatment option—with one in three saying it has helped them to eliminate the use of prescription drugs—according to a new poll. The survey from the medical marijuana certification company Green Health Docs, which involved interviews with 1,450 patients nationwide, asked a variety of questions about how cannabis impacts their chronic pain. Eight-six percent said that cannabis improved their pain at least moderately, with 56 percent saying they say “significant” reductions in pain. Nearly half of respondents—48 percent—said they were using prescription pain medications before trying marijuana. After using cannabis, 35 percent stopped all prescription pain medications, 15 percent stopped using some and 12 percent reduced their dosage or frequency. Fewer than one in five (18 percent) reported no change in prescription pain medication consumption following the initiation of medical cannabis use. “Many participants highlighted the lower risk of overdose compared to opioids, a more manageable side-effect profile, and the flexibility of different product formats,” the polling report from Green Health Docs says. “These factors explain why so many choose cannabis as a safer long-term strategy.” Almost a fourth of patients in the survey (73 percent) said they rely on use of marijuana to relieve pain on a daily basis, and most also said they believe cannabis to be a viable long-term solution for managing chronic pain—with just over one percent saying they disagree with that notion. “Respondents frequently described secondary benefits, such as better sleep, increased mobility, and reduced anxiety,” Dr. Anand Dugar of Green Health Docs said. “These improvements compound to make a meaningful difference in day-to-day life.” This represents one of the latest pieces of evidence that marijuana can serve as an effective substitute for opioids in pain management treatment. Another study, published in the journal Pain Management in August, determined that “co-prescription of cannabinoids may enable patients to reduce their opioid consumption prescribed for chronic benign pain.” Earlier this year, a different study in the journal Drug and Alcohol Review found that, among drug users who experience chronic pain, daily cannabis use was linked to a higher likelihood of quitting the use of opioids—especially among men. A study published late last year also found that legalizing medical cannabis appeared to significantly reduce monetary payments from opioid manufacturers to doctors who specialize in pain, with authors finding “evidence that this decrease is due to medical marijuana becoming available as a substitute” for prescription painkillers. Other recent research also showed a decline in fatal opioid overdoses in jurisdictions where marijuana was legalized for adults. That study found a “consistent negative relationship” between legalization and fatal overdoses, with more significant effects in states that legalized cannabis earlier in the opioid crisis. Authors estimated that recreational marijuana legalization “is associated with a decrease of approximately 3.5 deaths per 100,000 individuals.” “Our findings suggest that broadening recreational marijuana access could help address the opioid epidemic,” that report said. “Previous research largely indicates that marijuana (primarily for medical use) can reduce opioid prescriptions, and we find it may also successfully reduce overdose deaths.” Another recently published report into prescription opioid use in Utah following the state’s legalization of medical marijuana found that the availability of legal cannabis both reduced opioid use by patients with chronic pain and helped drive down prescription overdose deaths statewide. Overall, results of the study indicated that “cannabis has a substantial role to play in pain management and the reduction of opioid use,” it said. Yet another study, published in 2023, linked medical marijuana use to lower pain levels and reduced dependence on opioids and other prescription medications. And another, published by the American Medical Association (AMA) last February, found that chronic pain patients who received medical marijuana for longer than a month saw significant reductions in prescribed opioids. About one in three chronic pain patients reported using cannabis as a treatment option, according to a 2023 AMA-published report. Most of that group said they used cannabis as a substitute for other pain medications, including opioids. Other research published that year found that letting people buy CBD legally significantly reduced opioid prescription rates, leading to 6.6 percent to 8.1 percent fewer opioid prescriptions. A 2022 research paper that analyzed Medicaid data on prescription drugs, meanwhile, found that legalizing marijuana for adult use was associated with “significant reductions” in the use of prescription drugs for the treatment of multiple conditions. A 2023 report linked state-level medical marijuana legalization to reduced opioid payouts to doctors—another datapoint suggesting that patients use cannabis as an alternative to prescription drugs when given legal access. Researchers in another study, published last year, looked at opioid prescription and mortality rates in Oregon, finding that nearby access to retail marijuana moderately reduced opioid prescriptions, though they observed no corresponding drop in opioid-related deaths. Other recent research also indicates that cannabis may be an effective substitute for opioids in terms of pain management. A report published recently in the journal BMJ Open, for instance, compared medical marijuana and opioids for chronic non-cancer pain and found that cannabis “may be similarly effective and result in fewer discontinuations than opioids,” potentially offering comparable relief with a lower likelihood of adverse effects. Separate research published found that more than half (57 percent) of patients with chronic musculoskeletal pain said cannabis was more effective than other analgesic medications, while 40 percent reported reducing their use of other painkillers since they began using marijuana. The post Medical Marijuana Effectively Treats Chronic Pain And Helps Patients Reduce Prescription Drug Use, Survey Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Florida court has ruled that police cannot search a person’s vehicle based only on the smell of marijuana. The District Court of Appeal of Florida Second District on Wednesday issued an opinion, authored by Judge Nelly Khouzam, overturning a lower court decision that upheld the “plain smell doctrine” that has long permitted cannabis odor to be used as a pretense for vehicle searches. The policy was challenged in district court after a man had his probation revoked when police pulled over a car he was in, claimed to smell marijuana, forced the occupants to exit the vehicle to conduct a search and discovered cannabis and pills. But while it might have made sense in the past to use cannabis odor as a pretext for a search when it was strictly prohibited, the state’s laws have “fundamentally” changed, the appellate court said, referencing the legalization of hemp and medical marijuana in Florida. “For generations, cannabis was illegal in all forms—thereby rendering its distinct odor immediately indicative of criminal activity. But several legislative amendments over the years have fundamentally changed its definition and regulation,” it said. “The cumulative result is that cannabis is now legal to possess in multiple forms, depending on discrete characteristics such as where it was procured or its chemical concentration by weight.” “We are obligated under well-established constitutional principles to give meaning and effect to the legislature’s significant amendments to cannabis regulation,” the opinion, first reported by News Service of Florida, said. “In light of significant legislative amendments to the definition and regulation of cannabis, its mere odor can no longer establish that it is ‘immediately apparent’ that the substance is contraband. Accordingly, the plain smell doctrine can no longer establish probable cause based solely on the odor of cannabis. Rather, we now align the Fourth Amendment analysis for cannabis with the test that applies to other suspected contraband, such that its odor is a valid factor to be considered along with all others under the totality of the circumstances.” The court also said the issue is a question of “great public importance” for the Florida Supreme Court to look at and eventually resolve. Cannabis reform enjoys majority support in Florida, according to multiple polls that led up to a vote on an adult-use legalization ballot initiative last year. It ultimately fell short of the steep 60 percent threshold for passage, and part of the opposition came from the Florida Police Chiefs Association (FPCA) and the Florida Sheriffs Association (FSA). But amid the state-level legalization movement, courts and lawmakers have grappled with how to revising policing policies to comply with laws permitting cannabis for medical or recreational use. In June, for example, Chicago police officials announced an update to city law enforcement guidance to discourage officers from searching vehicles based merely on the smell of raw, unburnt marijuana. The revised policy came amid efforts to respond to a state Supreme Court ruling late last year that said police are justified in searching a vehicle if they smell raw marijuana. Advocates and some lawmakers say the ruling is incongruous with a separate high court decision a few months earlier that found that the smell of burnt cannabis was insufficient cause to search a vehicle. In May, a House committee in Illinois had an initial hearing on a Senate-passed bill that would clarify that police may not stop or detain drivers, or search their vehicles, based solely on the smell of cannabis. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Critics of the use of marijuana odor as probable cause for vehicle stops and searches argue that that police disproportionately enforce drug laws against Black Americans and other people of color, and allowing stops based on the claimed smell of cannabis could increase enforcement bias. A number of other states have passed laws around the smell of cannabis to justify police searches. Prior to legalization taking effect in Maryland, for example, Gov. Wes Moore (D) allowed a bill to become law that prevents police from using the odor or possession of cannabis alone as the basis of a search. GOP lawmakers unsuccessfully attempted to reverse that policy. The Minnesota Supreme Court also ruled last year that police can’t use the smell of cannabis alone to justify vehicle searches—a ruling that has since been codified by the legislature and signed into law by Gov. Tim Walz (D). And in New York in May, Gov. Kathy Hochul (D) signed a budget bill into law that notably does not include a controversial marijuana provision she proposed that would have allowed police to use the smell of marijuana as probable cause that a driver is impaired and then force them to take a drug test. Amendments by lawmakers removed the provision, which a coalition of 60 reform groups had argued in a letter to Hochul and top lawmakers would “repeat some of the worst harms of the War on Drugs” and allow law enforcement to “restart unconstitutional racial profiling of drivers.” Photo elements courtesy of rawpixel and Philip Steffan. The post Florida Court Blocks Police From Using The Smell Of Marijuana Alone To Search Vehicles appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Lawmakers in New York are revisiting the possibility of reforming the state’s laws related to psychedelics, convening a hearing to take testimony about the potential health benefits psilocybin. On Tuesday, the Assembly Health Committee spent hours discussing the the medical value of the main ingredient in so-called “magic mushrooms,” with numerous experts and advocates speaking about the issue as legislators weighed the science and possible regulations of the novel therapy. The chairwoman of the panel, Assemblymember Amy Paulin (D), introduced a bill to legalize psilocybin for adults last year, provided they obtain a permit after undergoing a health screening and educational course. “The committee is very interested in hearing the testimony to see what we can do about perhaps making [psychedelics] legal and appropriate for medical providers to dispense a product that they, frankly, have been acknowledging is effective for their patients, but have been unable in New York to legally prescribe it,” she said. The GOP ranking member of the committee, Assemblymember Josh Jensen (R), said in opening remarks that “certainly with the fast pace of the session in Albany, any chance we have to gather subject matter experts and talk about some of the more nuanced aspects of policy we may take up in coming legislative sessions, is critically important for the development of better public policy.” Joseph McKay, a retired New York City firefighter who was at the World Trade Center on 9/11, told lawmakers at the hearing that psilocybin “gave me my life back” after enduring “excruciating” pain from cluster headaches. “The truth is that so many people in New York are already buying and using psilocybin, but they’re doing so with no regulations on what they’re purchasing and no education on how to safely use the medication,” McKay said, as reported by Gothamist. “New York needs a system where people can purchase safe and regulated psilocybin with law-abiding people, including first responders and health care professionals.” Paulin, the committee chair, said in a press release that the expert testimony from the hearing “makes it clear that psilocybin shows great promise for treating debilitating conditions like cluster headaches, depression, PTSD and chronic pain, which have been resistant to traditional therapies.” “As we consider legislation to expand access in New York, our priority must be establishing framework that maximizes safety and ensures proper oversight for patients and providers,” she said. The lawmaker added that “too many New Yorkers are suffering from mental health conditions and chronic pain without adequate relief.” “It’s time for us to explore how we can safely expand access to this therapy while protecting public health,” Paulin said. “We have an obligation to pursue every avenue that could bring relief to those who are struggling with debilitating conditions.” New York legislators have taken special interest in psychedelics reform in recent sessions. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — For example, in January, Assemblymember Linda Rosenthal (D) filed legislation calling for the legalization of certain entheogenic substances such as psilocybin and ibogaine for adults 21 and older. The bill would amend state statute to make legal the “possession, use, cultivation, production, creation, analysis, gifting, exchange, or sharing by or between natural persons of twenty-one years of age or older of a natural plant or fungus-based hallucinogen.” DMT, ibogaine, mescaline, psilocybin and psilocyn would fall under the definition of “natural plant or fungus-based hallucinogens” that would be legalized by the bill. Rosenthal’s measure was introduced just days after another New York lawmaker, Sen. Nathalia Fernandez (D), prefiled a measure that would legalize psilocybin therapy for patients with qualifying conditions. Under that proposal, people could receive psilocybin treatment from a certified facilitator in a clinical setting, or at their home if they’re unable to travel. Patients and facilitators would receive protections against state-level prosecution. Fernandez also filed an earlier version of the bill last session, but it did not move out of committee either. Only minor technical changes have been made in the latest iteration. Bicameral New York lawmakers said at a briefing last year that there was a “real chance” that legislation to legalize psilocybin-assisted therapy would advance through committee, emphasizing that delaying action would “neglect” many “people who need help” with certain mental health conditions. That did not ultimately materialize, however. “We’re in a mental health crisis, and so we need every tool that’s available to us,” Assemblymember Pat Burke (D), who sponsored another bill to create a psilocybin therapy pilot program for 10,000 people, said. He added that “we’re here to turn the page” on the broader drug war. The post New York Lawmakers Hold Hearing Psilocybin’s Medical Benefits Amid Broader Debate Over Psychedelics Reform appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I did so delight in examining articles or blog posts placed here. There're outstanding possesses many practical facts. https://michelsonne.com/content/pages/1xbet_promo_code_india_today_bonus.html

“The places that we’ve identified today are nothing but weed dealers in strip malls.” By Sherman Smith, Kansas Reflector Kansas Bureau of Investigation director Tony Mattivi and Attorney General Kris Kobach (R) announced a crackdown Wednesday on “brazen” sales of marijuana and THC products as law enforcement raided 10 shops in six cities across the state. The two spoke to reporters at a news conference in Topeka while the raids were underway, and they said additional stores would be targeted later Wednesday and again on Thursday. Mattivi said the KBI was targeting illegal retail drug sales because teenagers were suffering dire health consequences from consuming products with high concentrations of THC. “I was at one of these locations earlier today,” Mattivi said. “The violations of the Kansas Controlled Substances Act are brazen. These places are selling pre-rolled marijuana cigarettes. They’re selling marijuana bud. They’re selling marijuana flower in canisters and cigarette by cigarette. “The places that we’ve identified today are nothing but weed dealers in strip malls, and we cannot continue to not enforce our controlled substance laws when we have these substances causing bad effects on Kansas kids.” Mattivi said a Kansas child would face less resistance buying marijuana than tobacco cigarettes. “That has to come to an end, and that’s what we did today,” he said. The KBI and local law enforcement spent weeks planning the raids in locations where local prosecutors had agreed to bring charges, Mattivi said. The initial wave of targets included smoke and vape shots in Concordia, McPherson, Pratt, Salina, Topeka and Wichita. The seized products would be sent to KBI or private labs for testing, Mattivi said. While Kansas is surrounded by states that have legalized marijuana to some extent, the drug remains illegal here. Kansas lawmakers have considered bills in recent years that would legalize marijuana for medicinal purposes, and the House passed legislation in 2021, but Senate leadership has stonewalled various proposals. The issue is expected to resurface in the next year’s legislative session, ahead of election season. For now, Kobach said, the laws have to be enforced. And, he said, there are many illegal products available at stores in Kansas, including THC vapes and THC teas. “In recent years, enforcement of our laws against marijuana and THC in Kansas have been intermittently or, in some jurisdictions, not enforced at all,” Kobach said. “And so this is an announcement that that period of lax enforcement is ending, and the KBI has taken the lead in identifying places that have become particularly brazen in their selling of marijuana products.” Kobach and Mattivi traced the rise in illegal sales to the 2018 Farm Bill passed by Congress that legalized some hemp products. “Since the Farm Bill passed, there’s been a growing acceptance of some of these products, whether they’re CBD or or THC,” Mattivi said. “Over time, these shops, I think, have pushed the envelope and pushed the envelope and pushed the envelope.” Some of the products, Mattivi said, contain 75-95 percent pure THC. “Part of the problem that we’re dealing with when it comes to THC and marijuana is that there has been a continuous rise in the concentration, or the level of purity, the level of THC, that’s present in these products,” Mattivi said. “This isn’t the 6 or 7 percent THC ditch weed that a lot of people in this state are familiar with.” The KBI said the following stores were raided midday Wednesday: Two EZ Smoke and Vape locations in Wichita, Whiskey River Trading in Pratt, Cigarette Outlet in Pratt, Pratt Tobacco and Vape in Pratt, Space Out Smoke Vapor & Tobacco in Salina, Vapor 100 in Salina, Mountain Gypsy Vape Shop in Concordia, The Hanging Leaf in McPherson, and Sacred Leaf in Topeka. This story was first published by Kansas Reflector. The post Kansas Law Enforcement Launches Raids Against ‘Brazen’ Cannabis Sales In Storefronts appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

This is certainly hence attractive plus artistic. I like a colorations plus whichever company may get them while in the mailbox might be smiling. https://institutocea.com/layouts/inc/?odin_deny_v_lyeghe_dostoprimechatelynosti_kotorye_nughno_uvidety.html

This is actually the kind of information I have been trying to find. Thank you for writing this information. 신용카드현금화 This is actually the kind of information I have been trying to find. Thank you for writing this information. 먹튀검증사이트

Keeping with his recent parody of President Donald Trump’s social media style, California Gov. Gavin Newsom (D) said on Wednesday that he’s assuming the role of “leader of the free world” in light of the federal government shutdown—and part of his platform will be to legalize marijuana. People will be “high on patriotism,” he said in a post on X. As Congress continues to struggle to reach an agreement on government funding legislation, Newsom took another opportunity to poke fun at the president, whom he’s routinely goaded with social media posts mimicking Trump’s rhetoric over recent weeks. “GOOD NEWS PATRIOTS! WITH WASHINGTON SHUT DOWN, I, GAVIN C. NEWSOM, AM NOW THE LEADER OF THE FREE WORLD,” the governor said, while listing legislative priorities that include universal health care, employment opportunities, free eggs, hair gel subsidies and a plan to “LEGALIZE CANNABIS!” “CRIME WILL STAY LOW AND EVERYONE WILL BE HIGH ON PATRIOTISM,” Newsom said on his X account, parroting Trump’s use of all-caps social media posts. “AND NO MORE TICKETMASTER FEES (FOR THE SWIFTIES, FEES STAY FOR KID ROCK!) THEY WILL CHANT USA! USA! BECAUSE WE WILL BE BACK AND “HOTTER” THAN EVER BEFORE. THANK YOU!” GOOD NEWS PATRIOTS! WITH WASHINGTON SHUT DOWN, I, GAVIN C. NEWSOM, AM NOW THE LEADER OF THE FREE WORLD. MY PLATFORM IS VERY SIMPLE: HEALTH CARE FOR ALL AMERICANS (NO MEASLES!), FREE SCHOOL MEALS (WOW PUDDING FOR EVERYONE), FREE CHILDCARE (THE MOMS LOVE ME! MORE BABIES!!)… — Governor Newsom Press Office (@GovPressOffice) October 1, 2025 Newsom was one of the first high-profile politicians to endorse legalization years before voters in his state moved forward with the reform. Of course, the post on Wednesday isn’t meant to be taken seriously. Rather, it’s meant to replicate Trump’s boastful social media strategy. The post came on the same day that a California law the governor approved took effect that delays a tax hike on marijuana sales for three years. With respect to the president, Trump said in late August that he would soon be making a decision on a proposal to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). He previously endorsed the reform on the campaign trail, but he was less clear in recent comments about where he stands on the policy proposal. Rescheduling would not legalize marijuana, however, as the California governor jokingly said he would accomplish as “leader of the free world.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — While a decision on rescheduling remains pending, Trump did share a post on social media over the weekend that touted the health benefits of hemp-derived CBD, particular for seniors. One of Trump’s longtime advisors, Roger Stone, subsequently said that his administration has an opportunity to move forward with marijuana rescheduling—or, even broader legalization—in a way that Democrats who regularly tout the reform failed to achieve when they controlled the White House and Congress. Meanwhile, the Republican Senate sponsor of a bipartisan cannabis banking bill said recently that Trump rescheduling marijuana would be an “important domino” to advance his legislation. Image element courtesy of Gage Skidmore. The post Gavin Newsom Jokes He’ll Legalize Marijuana As ‘Leader Of The Free World’ And Get People ‘High On Patriotism’ Amid Federal Shutdown appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I read your blog frequently, and I just thought I’d say keep up the fantastic work! It is one of the most outstanding blogs in my opinion. boxers

CA marijuana tax break in effect; OR officials defend cannabis industry labor law; MA psychedelics vote; TX ag commissioner on hemp; NE licenses delay Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Your good deed for the day: donate to an independent publisher like Marijuana Moment and ensure that as many voters as possible have access to the most in-depth cannabis reporting out there. Support our work at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW U.S. Customs and Border Protection is calling marijuana a “deadly” drug—touting agents’ efforts to seize it and other illegal substances—while also warning that possessing cannabis, even for medical use, carries “serious consequences.” The Massachusetts legislature’s Joint Committee on Health Care Financing approved a bill to create a psychedelic therapy pilot program—while two other panels held hearings on additional psilocybin-focused legislation. A new California law reversing a marijuana tax increase through at least late 2028 took effect, weeks after Gov. Gavin Newsom (D) signed a bill he said is aimed at ensuring “the legal market can continue to grow, consumers can access safe products, and our local communities see the benefits.” Texas Agriculture Commissioner Sid Miller (R) sent a letter pushing back against a senator’s “incorrect assertions” about the state’s compliance with federal hemp laws—but also signaled changes may be coming to measure “total THC” to determine the legality of hemp products. Lawyers for Oregon Gov. Tina Kotek (D) and other state officials are asking the U.S. Court of Appeals for the Ninth Circuit to overturn a judge’s ruling that blocked a voter-approved law to require marijuana businesses to enter into labor peace agreements with workers. The Nebraska Medical Cannabis Commission missed a deadline to issue the first marijuana cultivation business licenses in the wake of several regulators’ resignations. Michigan marijuana businesses held a rally to push against a tax increase bill that’s advancing in the legislature—and several lawmakers suggested that the proposed hike could be reduced by the time it potentially passes. / FEDERAL A Department of Veterans Affairs official discussed drug harm reduction policies on a podcast. / STATES North Carolina’s attorney general and secretary of state expressed concerns about THC-infused treats around Halloween. A Wisconsin senator spoke about a family member’s experience using medical cannabis. The Washington, D.C. Court of Appeals dismissed petitions challenging approval of a medical cannabis business license. Colorado regulators issued a health and safety bulletin about marijuana products manufactured with ingredients that contain pesticides above acceptable limits. Massachusetts’s top marijuana regulator laid out her priorities upon retaking the position following a now-reversed suspension. Ohio regulators are being sued over rules on marijuana products and advertising. Guam regulators posted draft hemp rules. California regulators published an updated list of pesticides allowed to be used on cannabis. Rhode Island Cannabis Advisory Board subcommittees will meet on Thursday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The Omaha, Nebraska City Council approved medical cannabis business zoning rules. Oakland, California’s Cannabis Regulatory Commission will meet on Thursday. / INTERNATIONAL The German federal government rejected Frankfurt’s plans to launch cannabis sales as part of a research program. / SCIENCE & HEALTH A study found that “CBD attenuates amygdala response to negative emotional stimuli in individuals with alcohol use disorder.” A study suggested that “psilocybin-occasioned mystical-type experiences play a pivotal role in enhancing mental wellness, leading to positive behavioural change, including cessation of harmful habits such as alcohol and nicotine use.” / ADVOCACY, OPINION & ANALYSIS The Last Prisoner Project and the Balanced Veterans Network held lobby days for cannabis reform on Capitol Hill. / BUSINESS Trulieve told a federal court that an insurance company owned by Berkshire Hathaway must provide a legal defense for the company in a lawsuit it is facing over a worker’s death. Verano Holdings Corp. announced the closing of a credit agreement to provide it with a revolving credit facility of $75 million. / CULTURE Former football player Jim McMahon authored a letter urging President Donald Trump to reschedule marijuana. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post Feds say cannabis is a “deadly” drug (Newsletter: October 2, 2025) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Wow, excellent post. I'd like to draft like this too - taking time and real hard work to make a great article. This post has encouraged me to write some posts that I am going to write soon. hide fashion

Ever tried a strain that just melts away stress? I recently had the DVF Banana Punch and the smooth hit and happy vibes were exactly what I needed after a hectic week. Their flower is just top tier! Could that relaxation prepare me to survive a night at Five Nights At Freddy's ?